1-3 of 3
Alvin Milner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Tolerability of Combination Therapy with Thalidomide and 5-Azacitidine in Patients with Advanced Myelodysplastic Syndromes (MDS).

Melita K Kenealy, MBBS, FRACP, FRCPA, John F Seymour, MBBS, PhD, FRACP, Cowan Linda, Alvin Milner, Pratyush Giri, Shir-Jing Ho, MBBS, FRACP, FRCPA, Warwick Benson, Andrew Nicol, MBBS, FRCPA, FRACP, PhD, Philip Campbell, MBBS, FRACP, FRCPA, Ian Prosser, MBBS, FRACP, FRCPA, PhD, Craig Underhill, MBBS, FRACP, Ilona Cunningham, Anthony K. Mills, MBBS, FRACP, FRCPA, Jeffrey Szer, MBBS, FRACP, Peter Presgrave, MBBS, FRACP, FRCPA, PhD, Robin Filshie, MBChB, FRACP, FRCPA, PhD
Journal: Blood
Blood (2009) 114 (22): 1749.
https://doi.org/10.1182/blood.V114.22.1749.1749
Published: 2009
Journal Articles

Significant Reduction of BCR-ABL Transcripts after Switching to Imatinib Therapy in Patients with CML and Complete or Near-Complete Cytogenetic Responses to Interferon-Alpha (IFN).

Susan Branford, Timothy Hughes, Steven Stylian, Anthony P. Schwarer, Chris Arthur, Robin Filshie, Susan Moreton, Robyn Rodwell, Nancy Guzzo-Pernell, Deb Taylor, Jenny Larson, Rachel Koelmayer, Alvin Milner, Kevin Lynch, Kerry McDonald Taylor
Journal: Blood
Blood (2006) 108 (11): 2142.
https://doi.org/10.1182/blood.V108.11.2142.2142
Published: 2006
Journal Articles

Increased Marrow CD57+ Cytotoxic T Cells Is a Powerful Prognostic Marker for Survival in Patients with Relapsed Multiple Myeloma (MM) Receiving Thalidomide.

Linda R. Mileshkin, MBBS, FRACP, Peter Gambell, PhD, Victoria Beshay, PhD, Yoshihiro Hayakawa, PhD, Mark Smyth, PhD, Melanie Trivett, PhD, Paul J. Simmons, PhD, Alvin Milner, PhD, Astat, Jerome B. Zeldis, MD, FACP, Miles Prince, MD, FRACP
Journal: Blood
Blood (2005) 106 (11): 3486.
https://doi.org/10.1182/blood.V106.11.3486.3486
Published: 2005